Non-invasive assessment of hepatic fibrosis in a series of patients with Wilson's Disease

被引：36

作者：

Sini, Margherita ^{[1
]}

Sorbello, Orazio ^{[1
]}

Civolani, Alberto ^{[1
]}

Liggi, Mauro ^{[1
]}

Demelia, Luigi ^{[1
]}

机构：

[1] Azienda Osped Univ Cagliari, Dept Gastroenterol, I-09130 Cagliari, Italy

来源：

DIGESTIVE AND LIVER DISEASE | 2012年 / 44卷 / 06期

关键词：

Hepatic fibrosis; Noninvasive tests; Transient elastography Wilson's Disease; TRANSIENT ELASTOGRAPHY; LIVER-BIOPSY; DIAGNOSIS; COMPLICATIONS; CIRRHOSIS;

D O I：

10.1016/j.dld.2011.12.010

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

Background/aims: Liver biopsy has always represented the standard of reference in hepatic fibrosis assessment. Recently, blood markers and instrumental methods have been proposed for non-invasive assessment. The aim of this study was to validate transient elastography and other non-invasive tests compared to liver histology in Wilson's Disease. Methods: Liver stiffness in 35 Wilson's Disease patients was evaluated by Fibroscan, serum fibrosis markers (AST-to-platelet-ratio index and FIB-4) and biopsy. Results: Compared to liver histology, the FibroScan values increased proportionally with progression of the histological fibrosis stage. Significant fibrosis could be predicted with a Fibroscan cut-off value of 6.6 kPa. Advanced fibrosis could be predicted with a FibroScan cut-off value of 8.4 kPa. Serum fibrosis marker values gave good correlation with hepatic stage. Conclusions: A FibroScan value of 6.6 kPa was found to be a significant separation limit for differentiating significant fibrosis stages from milder stages and a fibroscan value of 8.4 kPa was found to be a significant separation limit for differentiating advanced fibrosis stages from milder stages. FibroScan values are clinically useful for predicting fibrosis stages and helpful in managing chronic therapy in Wilson's Disease patients. (C) 2011 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.

引用

页码：487 / 491

页数：5

共 18 条

[11] Projecting future complications of chronic hepatitis C in the United States [J].

Davis, GL ;

Albright, JE ;

Cook, SF ;

Rosenberg, DM .

LIVER TRANSPLANTATION, 2003, 9 (04) :331-338

[12]

de Lédinghen V, 2006, JAIDS-J ACQ IMM DEF, V41, P175

[13] Transient elastography for diagnosing liver cirrhosis [J].

Erhardt, A. ;

Loerke, J. ;

Vogt, C. ;

Poremba, C. ;

Willers, R. ;

Sagir, A. ;

Haeussinger, D. .

DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2006, 131 (49) :2765-2769

[14] Diagnosis of cirrhosis by transient elastography (FibroScan):: a prospective study [J].

Foucher, J ;

Chanteloup, E ;

Vergniol, J ;

Castéra, L ;

Le Bail, B ;

Adhoute, X ;

Bertet, J ;

Couzigou, P ;

de Lédinghen, V .

GUT, 2006, 55 (03) :403-408

[15] Performance of transient elastography for the staging of liver fibrosis: A meta-analysis [J].

Friedrich-Rust, Mireen ;

Ong, Mei-Fang ;

Martens, Swantje ;

Sarrazin, Christoph ;

Bojunga, Joerg ;

Zeuzem, Stefan ;

Herrmann, Eva .

GASTROENTEROLOGY, 2008, 134 (04) :960-974

[16] Transient elastography:: a valid alternative to biopsy in patients with chronic liver disease [J].

Gomez-Dominguez, E. ;

Mendoza, J. ;

Rubio, S. ;

Moreno-Monteagudo, J. A. ;

Garcia-Buey, L. ;

Moreno-Otero, R. .

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2006, 24 (03) :513-518

[17] Noninvasive diagnosis of hepatic fibrosis or cirrhosis [J].

Oberti, F ;

Valsesia, E ;

Pilette, C ;

Rousselet, MC ;

Bedossa, P ;

Aube, C ;

Gallois, Y ;

Rifflet, H ;

Maiga, MY ;

PenneauFontbonne, D ;

Cales, P .

GASTROENTEROLOGY, 1997, 113 (05) :1609-1616

[18] COMPLICATIONS FOLLOWING PERCUTANEOUS LIVER-BIOPSY - A MULTICENTER RETROSPECTIVE STUDY ON 68 276 BIOPSIES [J].

PICCININO, F ;

SAGNELLI, E ;

PASQUALE, G ;

GIUSTI, G .

JOURNAL OF HEPATOLOGY, 1986, 2 (02) :165-173

← 1 2 →